1.Relationship of TAZ expression between peripheral blood and tumor tissue in patients with colorectal cancer and its clinical significance
Aijun WANG ; Hongyu WANG ; Jinheng XU ; Baojun ZHENG ; Xiao WU ; Jian CHENG ; Chao ZHANG ; Hua SHI ; Junwei FENG
Chongqing Medicine 2017;46(28):3915-3916,3919
Objective To investigate the expression of TAZ in peripheral blood and tumor tissue of the patients with colorectal cancer and to analyze their relationship and clinical significance.Methods Eighty-five cases of pathologically verified colorectal cancer treated by radical operation were selected as the operation group,and 35 cases with postoperative relapse served as the recurrent group.Meanwhile 50 age and sex-matched healthy persons were selected as the control group.The immunohistochemical(SP)technique was adopted to detect the expression of TAZ in tumor tissues and expression of TAZ in peripheral blood was tested with enzyme linked immunosorbent assay(ELISA).Results The level of preoperative TAZ in peripheral blood of the operation group was significantly higher than that of the control group(P<0.05).The level of peripheral blood TAZ after operation in the operation group had no significant change compared with the control group (P>0.05).The level of peripheral blood TAZ in the recurrent group was significantly higher than preoperative level of operation group(P<0.05).The expression of tumor tissue TAZ was significantly higher than that of normal mucosal tissue(P<0.05);the expression of tumor tissue TAZ in the recurrent group was higher than that in the operation group(P<0.05).The tumor tissue TAZ level in the operation group and recurrent group had obvious correlation with peripheral blood TAZ level(P<0.05).Conclusion Monitoring the TAZ level has obvious reference value for predicting colorectal cancer staging and timely understanding tumor recurrence.
2.Correlation analysis between tumor burden and biochemical indicators of parathyroid adenoma
Qingyuan ZHENG ; An SONG ; Tianqi CHEN ; Sen YANG ; Jinheng XIAO ; Ya HU ; Quan LIAO
Chinese Journal of Endocrine Surgery 2024;18(1):35-39
Objective:To determine the correlation of tumor volume and weight with biochemical parameters in patients with parathyroid adenoma (PA) .Methods:A prospective electronic database collected clinical data on 208 patients with PA treated for the first time by surgery at department of general surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College.The relationship between biochemical parameters and tumor volume and weight was analyzed with Spearman’s correlation.Results:Tumor volume and weight were positively correlated with parathyroid hormone (PTH) ( r=0.33, P<0.001; r=0.39, P<0.001), calcium ( r=0.16, P=0.018; r=0.18, P=0.007) and alkaline phosphatase levels ( r=0.24, P<0.001; r=0.27, P<0.001), respectively. Clinical correlates affecting serum PTH were age, serum calcium and tumor weight ( F=30.325, P<0.001) . Conclusions:Tumor burden in patients with PA correlates with some laboratory biochemical parameters. Age and cystic lesions of the tumor may influence the actual serum PTH levels.
3.Orange-derived extracellular vesicles nanodrugs for efficient treatment of ovarian cancer assisted by transcytosis effect.
Feng LONG ; Yao PAN ; Jinheng LI ; Suinan SHA ; Xiubo SHI ; Haoyan GUO ; Chuanqing HUANG ; Qian XIAO ; Chao FAN ; Xingmei ZHANG ; Jun-Bing FAN ; Ying WANG
Acta Pharmaceutica Sinica B 2023;13(12):5121-5134
Extracellular vesicles (EVs) have recently received much attention about the application of drug carriers due to their desirable properties such as nano-size, biocompatibility, and high stability. Herein, we demonstrate orange-derived extracellular vesicles (OEV) nanodrugs (DN@OEV) by modifying cRGD-targeted doxorubicin (DOX) nanoparticles (DN) onto the surface of OEV, enabling significantly enhancing tumor accumulation and penetration, thereby efficiently inhibiting the growth of ovarian cancer. The obtained DN@OEV enabled to inducement of greater transcytosis capability in ovarian cancer cells, which presented the average above 10-fold transcytosis effect compared with individual DN. It was found that DN@OEV could trigger receptor-mediated endocytosis to promote early endosome/recycling endosomes pathway for exocytosis and simultaneously reduce degradation in the early endosomes-late endosomes-lysosome pathway, thereby inducing the enhanced transcytosis. In particular, the zombie mouse model bearing orthotopic ovarian cancer further validated DN@OEV presented high accumulation and penetration in tumor tissue by the transcytosis process. Our study indicated the strategy in enhancing transcytosis has significant implications for improving the therapeutic efficacy of the drug delivery system.